GleamWall
中文EN

LCTC Lifeloc Technologies, Inc

Laboratory Analytical Instruments · OTC · SEC CIK 1493137 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.0%
TTM net income YoY-49.9%
TTM EPS YoY-50.0%
Revenue 3-yr CAGR1.0%
Net income 3-yr CAGR—

Margins

Gross margin42.7%
Operating margin-6.5%
Net margin-19.9%
FCF margin-3.8%
EBITDA margin-3.0%

Returns

ROE-40.5%
ROA-24.7%
ROIC (approx.)-9.9%
Asset turnover1.25x

Leverage & solvency

Liabilities / assets46.7%
Debt / equity0.27x
Current ratio3.95x
Interest coverage-4.24x

Cash quality & payout

Operating cash flow / net income-0.03x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue4.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.52M$2.44M$2.29M$2.27M$2.26M$2.22M$2.28M$1.91M
Cost of revenue$1.43M$1.35M$1.31M$1.37M$1.35M$1.29M$1.37M$1.20M
Gross profit$1.09M$1.09M$987,074$902,187$906,693$924,599$908,566$705,244
R&D expense$505,982$560,281$414,445$601,154$458,747$623,262$469,680$503,887
SG&A expense$319,223$314,853$387,402$322,503$340,705$340,074$384,878$305,852
Operating income-$50,071-$103,576-$128,002-$336,881-$234,326-$378,265-$280,548-$422,607
Interest expense$43,594$39,610$31,242$31,437$36,953$26,305$24,495$9,919
Pretax income-$84,931———-$263,439-$393,639-$292,686—
Income tax$0$0$0$1.16M$0$0$0-$112,706
Net income-$84,931-$134,330-$152,713-$1.52M-$263,439-$393,639-$292,686-$312,827
EBITDA$27,100-$35,387-$60,229-$218,522-$125,650-$269,423-$178,142-$317,410
EPS (basic)-0.03-0.05-0.06—-0.10-0.14-0.11—
EPS (diluted)-0.03-0.05-0.06—-0.10-0.14-0.11—
Weighted avg. shares (diluted)2.75M2.75M2.75M—2.75M2.75M2.69M—
Balance sheet
Cash & equivalents$930,539$908,208$569,330$746,001$685,097$995,750$1.52M$1.24M
Receivables$785,442$826,715$850,341$772,380$864,456$765,730$761,697$732,541
Inventory$2.68M$2.84M$2.79M$2.63M$2.86M$2.99M$2.94M$3.00M
Current assets$4.55M$4.78M$4.37M$4.27M$4.61M$4.97M$5.68M$5.09M
PP&E, net$2.31M$2.19M$2.25M$2.30M$2.41M$2.41M$2.29M$2.38M
Intangibles$65,324$67,229$69,134$71,039$73,008$74,913$76,818$78,723
Total assets$7.00M$7.08M$6.74M$6.69M$8.30M$8.62M$9.22M$8.72M
Current liabilities$1.15M$1.10M$1.06M$836,870$907,861$956,094$1.13M$743,575
Short-term debt————$54,431$54,016$53,604$53,195
Long-term debt$1.02M$1.03M$1.04M$1.06M$1.07M$1.09M$1.10M$1.12M
Total debt$1.02M$1.03M$1.04M$1.06M$1.13M$1.14M$1.15M$1.17M
Total liabilities$3.27M$3.26M$2.79M$2.58M$2.68M$2.74M$2.94M$2.50M
Shareholders' equity$3.73M$3.82M$3.95M$4.10M$5.62M$5.89M$6.28M$6.23M
Net debt$85,632$122,156$475,119$312,425$441,631$144,328-$369,131-$71,399
Shares outstanding2.75M2.75M2.75M2.75M2.75M2.75M2.75M2.66M
Cash flow statement
Operating cash flow$247,959-$133,212-$129,365$79,118-$188,861-$289,219-$100,357-$291,791
Capital expenditure$0$0$5,370$423,283$16,700$22,810$0$62,108
Free cash flow$247,959-$133,212-$134,735-$344,165-$205,561-$312,029-$100,357-$353,899
Investing cash flow-$197,330$0-$19,781-$4,225-$107,905-$223,703-$18,548-$42,500
Financing cash flow-$28,298$472,090-$27,525-$13,989-$13,887-$13,785$397,616$736,416
Depreciation & amortization$77,171$68,189$67,773$118,359$108,676$108,842$102,406$105,197

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.